• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapid roll out of SARS-CoV-2 antibody testing-a concern.

作者信息

Andersson Monique, Low Nicola, French Neil, Greenhalgh Trisha, Jeffery Katie, Brent Andrew, Ball Jonathan, Pollock Allyson, McCoy David, Iturriza-Gomara Miren, Buchan Iain, Salisbury Helen, Pillay Deenan, Irving Will

机构信息

Department of Microbiology, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

出版信息

BMJ. 2020 Jun 24;369:m2420. doi: 10.1136/bmj.m2420.

DOI:10.1136/bmj.m2420
PMID:32580928
Abstract
摘要

相似文献

1
Rapid roll out of SARS-CoV-2 antibody testing-a concern.快速推出严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体检测——一个值得关注的问题。
BMJ. 2020 Jun 24;369:m2420. doi: 10.1136/bmj.m2420.
2
Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体检测的快速推广：即使在高特异性水平下，检测结果中仍有相当一部分会出现假阳性。
BMJ. 2020 Jul 22;370:m2910. doi: 10.1136/bmj.m2910.
3
Covid-19 antibody tests: a briefing.新冠病毒-19抗体检测：简报
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
4
Will antibody tests for the coronavirus really change everything?新冠病毒抗体检测真的会改变一切吗？
Nature. 2020 Apr;580(7805):571-572. doi: 10.1038/d41586-020-01115-z.
5
The early antibody response to SARS-Cov-2 infection.对SARS-CoV-2感染的早期抗体反应。
Clin Chem Lab Med. 2020 Sep 25;58(10):e201-e203. doi: 10.1515/cclm-2020-0617.
6
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.美国微生物学会2020年3月23日新型冠状病毒肺炎国际峰会报告：严重急性呼吸综合征冠状病毒2型/新型冠状病毒肺炎诊断检测的价值
mBio. 2020 Mar 26;11(2):e00722-20. doi: 10.1128/mBio.00722-20.
7
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.新型冠状病毒特异性 IgA 反应在 COVID-19 患者中的特征。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.01526-2020. Print 2020 Aug.
8
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.迈向严重急性呼吸综合征冠状病毒2血清学检测在临床实践中的合理应用。
Clin Chem Lab Med. 2020 Sep 25;58(10):e189-e191. doi: 10.1515/cclm-2020-0880.
9
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
10
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.

引用本文的文献

1
Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays.25 种自动化 SARS-CoV-2 血清学检测方法的全面、比较评估。
Microbiol Spectr. 2024 Jan 11;12(1):e0322823. doi: 10.1128/spectrum.03228-23. Epub 2023 Nov 29.
2
Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays.35 种手动 SARS-CoV-2 血清学检测方法的全面比较评估。
Microbiol Spectr. 2023 Jun 15;11(3):e0510122. doi: 10.1128/spectrum.05101-22. Epub 2023 May 9.
3
Stakeholders of the world, unite!: Hospitality in the time of COVID-19.
世界各利益相关方，联合起来！：新冠疫情时期的款待之道。
Int J Hosp Manag. 2021 May;95:102922. doi: 10.1016/j.ijhm.2021.102922. Epub 2021 Mar 27.
4
Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories.提高国家实验室应对 COVID-19 的效率：41 家实验室对 47 种商业 SARS-CoV-2 免疫测定试剂盒进行的全国多中心评估。
J Clin Microbiol. 2021 Aug 18;59(9):e0076721. doi: 10.1128/JCM.00767-21.
5
Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity.三种新型冠状病毒2型血清学化学发光免疫分析方法的比较及抗体指数与疾病严重程度的临床意义
PLoS One. 2021 Jun 29;16(6):e0253889. doi: 10.1371/journal.pone.0253889. eCollection 2021.
6
COVID-19 zugzwang: Potential public health moves towards population (herd) immunity.新冠疫情的强制局面：实现群体免疫的潜在公共卫生举措。
Public Health Pract (Oxf). 2020 Nov;1:100031. doi: 10.1016/j.puhip.2020.100031. Epub 2020 Dec 22.
7
Who Gets Cured? COVID-19 and Developing a Critical Medical Sociology and Anthropology of Cure.谁能被治愈？新冠疫情与构建关键的治愈医学社会学和人类学
Front Sociol. 2021 Jan 12;5:613548. doi: 10.3389/fsoc.2020.613548. eCollection 2020.
8
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.靶向 SARS-CoV-2 血清学检测在疑似漏诊、迟发或新冠后感染综合征诊断和管理中的临床应用：在第一波大流行期间实施的试点服务的结果。
PLoS One. 2021 Apr 7;16(4):e0249791. doi: 10.1371/journal.pone.0249791. eCollection 2021.
9
Perspectives and Challenges in the Fight Against COVID-19: The Role of Genetic Variability.抗击 COVID-19 的观点与挑战：遗传变异性的作用。
Front Cell Infect Microbiol. 2021 Mar 15;11:598875. doi: 10.3389/fcimb.2021.598875. eCollection 2021.
10
Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama.巴拿马献血者和医护人员中用于检测抗SARS-CoV-2 IgM和IgG抗体的即时检测的性能及血清流行率
Front Med (Lausanne). 2021 Mar 2;8:616106. doi: 10.3389/fmed.2021.616106. eCollection 2021.